Morgan Stanley Upgrades Amicus Therapeutics (FOLD) to Overweight
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung upgraded Amicus Therapeutics (NASDAQ: FOLD) from Equalweight to Overweight with a price target of $20.00 (from $15.00).
For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.
Shares of Amicus Therapeutics closed at $12.66 yesterday.
You May Also Be Interested In
- Enhanced Group Inc. (ENHA) PT Lowered to $5 at Canaccord
- Goldman Sachs Upgrades Lonking Holdings Limited (3339:HK) (LONKF) to Buy
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
